Background/Aims: The Solitaire stent has been suggested as a promising device to perform intracranial thrombectomy in large vessels. We report our experience. Methods: Consecutive patients in whom a thrombectomy with Solitaire stent had been performed for acute ischemic stroke in the Lyon Stroke Unit, France, from November 2009 to November 2010 were enrolled. Results: There were 12 patients with a mean age of 66 years and a mean baseline National Institutes of Health Stroke Scale score of 17.5. There were 10 cases of anterior cerebral artery and 2 cases of basilar artery occlusion. The mean time from onset of symptoms to recanalization was 306 min. Partial or total recanalization was obtained in 91.6% of patients. One case of periprocedural asymptomatic arterial dissection and 1 case of symptomatic cerebral hemorrhage occurred. At 90 days, 4 patients (33.3%) were dead and 5 patients (41.6%) had a modified Rankin Scale ≤2. Conclusions: In this case series, thrombectomy using Solitaire stent in stroke related to large vessel occlusion appears to be feasible, safe and potentially effective. Randomized controlled trials are needed to demonstrate the superiority of thrombectomy alone or in combination with intravenous tPA over intravenous tPA alone in ischemic stroke patients with large intracranial arterial occlusion.

1.
Saqqur M, Uchino K, Demchuk AM, Molina CA, Garami Z, Calleja S, Akhtar N, Orouk FO, Salam A, Shuaib A, Alexandrov AV, CLOTBUST Investigators: Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948–954.
2.
Schellinger PD, Kohrmann M, Hacke W: Thrombolytic therapy for acute stroke. Handbook Clin Neurol 2009;94:1155–1193.
3.
Mazighi M, Serfaty JM, Labreuche J, Laissy JP, Meseguer E, Lavallée PC, Cabrejo L, Slaoui T, Guidoux C, Lapergue B, Klein IF, Olivot JM, Abboud H, Simon O, Niclot P, Nifle C, Touboul PJ, Raphaeli G, Gohin C, Claeys ES, Amarenco P, RECANALISE investigators: Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009;8:802–809.
4.
Mathews MS, Sharma J, Snyder KV, Natarajan SK, Siddiqui AH, Hopkins LN, Levy EI: Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset. Neurosurgery 2009;65:860–865.
5.
Natarajan SK, Snyder KV, Siddiqui AH, Ionita CC, Hopkins LN, Levy EI: Safety and effectiveness of endovascular therapy after 8 hours of acute ischemic stroke onset and wake-up strokes. Stroke 2009;40:3269–3274.
6.
Rha JH, Saver JL: The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967–973.
7.
Grunwald IQ, Wakhloo AK, Walter S, et al: Endovascular stroke treatment today. AJNR Am J Neuroradiol 2011;32:238–242.
8.
Gobin YP, Starkman S, Duckwiler GR, et al: MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004;35:2848–2854.
9.
Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S, Gobin YP, Multi MERCI Investigators: Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205–1212.
10.
Bose A, Henkes H, Alfke K, et al, Penumbra Phase I Stroke Trial Investigators: The Penumbra System : a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409–1413.
11.
Brekenfeld C, Schroth G, Mattle H, Do D, Remonda L, Mordasini P, Arnold M, Nedeltchev K, Meier N, Gralla J: Stent placement in acute cerebral artery occlusion: use of a self-expandable intracranial stent for acute stroke treatment. Stroke 2009;40:847–852.
12.
Levy EI, Mehta R, Gupta R, Hanel RA, Chamczuk AJ, Fiorella D, Woo HH, Albuquerque FC, Jovin TG, Horowitz MB, Hopkins LN: Self-expanding stents for recanalization of acute cerebrovascular occlusions. AJNR Am J Neuroradiol 2007;28:816–822.
13.
Zaidat OO, Wolfe T, Hussain SI, Lynch JR, Gupta R, Delap J, Torbey MT, Fitzsimmons B-F: Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke 2008;39:2392–2395.
14.
Levy EI, Siddiqui AH, Crumlish A, Snyder KV, Hauck EF, Fiorella DJ, Hopkins LN, Mocco J: First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009;40:3552–3556.
15.
Castano C, Serena J, Davalos A: Use of the new Solitaire AB device for mechanical thrombectomy when MERCI clot retriever has failed to remove the clot: a case report. Interv neuroradiol 2009;15:209–214.
16.
Jahan R: Solitaire flow-restoration device for treatment of acute ischemic stroke: safety and recanalization efficacy study in a swine vessel occlusion model. AJNR Am J Neuroradiol 2010;31:1938–1943.
17.
Roth C, Papanagiotou P, Behnke S, et al: Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 2010;41:2559–2567.
18.
Castano C, Dorado L, Guerrero C, Millán M, Gomis M, Perez de la Ossa N, Castellanos M, García MR, Domenech S, Dávalos A: Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010;41:1836–1840.
19.
Costalat V, Machi P, Lobotesis K, Maldonado I, Vendrell JF, Riquelme C, Mourand I, et al: Rescue, combined, and stand-alone thrombectomy in the management of large vessel occlusion stroke using the Solitaire device: a prospective 50-patient single-center study: timing, safety, and efficacy. Stroke 2011;42:1929–1935.
20.
Miteff F, Faulder KC, Goh ACC, Steinfort BS, Sue C, Harrington TJ: Mechanical thrombectomy with a self-expanding retrievable intracranial stent (Solitaire AB): experience in 26 patients with acute cerebral artery occlusion. AJNR Am J Neuroradiol 2011;32:1078–1081.
21.
Stampfl S, Hartmann M, Ringleb PA, Haehnel S, Bendszus M, Rohde S: Stent placement for flow restoration in acute ischemic stroke: a single-center experience with the Solitaire stent system. AJNR Am J Neuroradiol 2011;32:1245–1248.
22.
Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D: Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:109–137.
23.
Berger C, Fiorelli M, Steiner T, Schabitz WR, Bozzao L, Bluhmki E, Hacke W, von Kummer R: Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001;32:1330–1335.
24.
Zhao H: Ischemic postconditioning as a novel avenue to protect against brain injury after stroke. J Cereb Blood Flow Metab 2009;29:873–885.
25.
Rouchaud A, Mazighi M, Labreuche J, Meseguer E, Serfaty JM, Laissy JP, et al: Outcomes of mechanical endovascular therapy for acute ischemic stroke: a clinical registry study and systematic review. Stroke 2011;42:1289–1294.
26.
Puetz V, Dzialowski I, Hill MD, Subramaniam S, Sylaja PN, Krol A, O’Reilly C, Hudon ME, Hu WY, Coutts SB, Barber PA, Watson T, Roy J, Demchuk AM, Calgary CTA Study Group: Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke 2008;3:230–236.
27.
Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA, IMS I and II Investigators: Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066–1072.
28.
Barber PA, Demchuk AM, Zhang J, Buchan AM: Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group: Alberta Stroke Programme Early CT Score. Lancet 2000;355:1670–1674.
29.
Trial and cost effectiveness evaluation of intra-arterial thrombectomy in acute ischemic stroke. http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01062698.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.